Philly’s Biotech Boom: Record VC funding and Top Workplaces
TLDR: Philly daily roundup Key Points: CEO Marvin Barron is considering Philadelphia for the HQ of Pearl Antigenics after participating in a program by the Science Center Philadelphia region raised $819 million